Atlas Trials

CIN1

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch CIN1

RecordFirmDate
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine (NCT05371353)Shanghai Bovax Biotechnology Co., Ltd.2022-05-14
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years (NCT05027776)Shanghai Bovax Biotechnology Co., Ltd.2021-09-15
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020)Shanghai Bovax Biotechnology Co., Ltd.2021-05-28
Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions (NCT04607850)Barinthus Biotherapeutics2021-03-16
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016)Shanghai Bovax Biotechnology Co., Ltd.2020-09-19
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04425291)Shanghai Bovax Biotechnology Co., Ltd.2020-05-28
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04422366)Shanghai Bovax Biotechnology Co., Ltd.2020-04-28
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101)Shanghai Bovax Biotechnology Co., Ltd.2018-10-10

Track CIN1 automatically

Every clearance here is in the API, with alerts when new ones post.